Showing results (21-30 of 2,311) with videos related to

Sort By:
Pageof 232
European Journal of Clinical Pharmacology|January 1, 1995
Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolismY Caraco, E Zylber-Katz, E M Berry, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|April 1, 1995
Caffeine pharmacokinetics in obesity and following significant weight reductionY Caraco, E Zylber-Katz, E M Berry, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Pharmacokinetic interaction between nifedipine and propranololE Zylber-Katz, M Turetz-Abramovitch, G Koren, et al.
Clinical Pharmacology and Therapeutics|May 1, 1992
Significant weight reduction in obese subjects enhances carbamazepine eliminationY Caraco, E Zylber-Katz, E M Berry, et al.
The Annals of Pharmacotherapy|February 1, 1995
Multiple drug interactions with cyclosporine in a heart transplant patientE Zylber-Katz
European Journal of Clinical Pharmacology|September 24, 1999
The effect of short-term dipyrone administration on cyclosporin pharmacokineticsY Caraco, E Zylber-Katz, M Fridlander, et al.
The Journal of Rheumatology|April 1, 1994
Colchicine disposition in patients with familial Mediterranean fever with renal impairmentE Ben-Chetrit, J M Scherrmann, E Zylber-Katz, et al.
European Journal of Clinical Pharmacology|December 1, 1998
Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyroneO Cohen, E Zylber-Katz, Y Caraco, et al.
European Journal of Clinical Pharmacology|November 9, 2001
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylatorsM Levy, R Safadi, E Zylber-Katz, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Cerebrospinal fluid prostaglandins after systemic dipyrone intakeM Levy, K Brune, E Zylber-Katz, et al.
Pageof 232